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Abstract
Pulmonary hamartomas are more common than expected because they are usually asymptomatic and are either
discovered on routine chest radiography or when they are noted incidentally in approximately 0.25 % of autopsies.
In contrast, pulmonary fibroleiomyomatous hamartoma, which consists of interlacing bundles of smooth muscle cells
admixed with fibrous tissue and numerous tubular or cleft-like epithelial inclusions, is a rare type of hamartoma.
Controversy exists regarding the pathogenesis of this tumor. We herein present a rare case of a 68-year-old male
patient without a pre-existing smooth muscle tumor, who underwent resection for a tumor that was considered to
be a true pulmonary fibroleiomyomatous hamartoma.
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Background
Hamartomas are a relatively common form of benign
lung tumor. Fibroleiomyomatous hamartomas, on the
other hand, are rare. Pulmonary fibroleiomyomatous
hamartoma was first described as “diffuse fibroleiomyo-
matous hamartomatosis” by Cruickshank et al. in 1953
[1]. To date, only five cases of solitary pulmonary fibro-
leiomyomatous hamartoma have been reported [2, 3].
These tumors represent an important group of benign
pulmonary tumors which classically present as incidental
“coin lesions” and which must be differentiated from pri-
mary and metastatic malignant neoplasms. We herein
present a rare case of a patient with a solitary pulmonary
fibroleiomyomatous hamartoma.
Case presentation
The patient was a 68-year-old asymptomatic male who
visited our hospital after an abnormal shadow was
suspected on a chest X-ray. He had undergone surgery
for colon cancer 8 years previously. He had no history of
smooth muscle tumors nor did he have any history of
occupational exposure to silica, beryllium, or asbestos.
Chest computed tomography (CT) revealed the presence
of a well-demarcated solid nodule in the right upper
lobe adjacent to the pleura, which measured 1.0 cm in
diameter (Fig. 1). A systemic CT scanning examination
revealed no tumors other than this pulmonary tumor.
We performed a wedge resection of the right upper
lobe by video-assisted thoracoscopic surgery (VATS).
Three ports were placed in the left lateral decubitus
position. The lung was deflated to confirm the right lung
nodule. A linear stapling device was used to resect the
lung nodule. The nodule was firm, solid, yellow-white in
color on sectioning (Fig. 2), and was not associated with
the bronchus or macroscopically visible bronchioles. A
frozen section revealed the proliferation of fibromuscu-
lar tissue without mitotic figures, suggesting that it was
a benign tumor, such as a leiomyoma. Consequently,
lobectomy was not performed. The postoperative course
was uncomplicated. The histopathological findings revealed
the proliferation of spindle cells with eosinophilic cyto-
plasm arranged in an interlacing bundle and bronchial
epithelium extending into the alveolar septa in the pulmon-
ary parenchyma without a cartilaginous or adipose element.
Mitotic figures were not observed (Fig. 3a). An immunohis-
tochemical analysis revealed that the spindle cells were
positive for alpha-smooth muscle actin (SMA) (Fig. 3b) and
HHF-35, focally positive for desmin and negative for estro-
gen receptor, progesterone receptor, Melan A, and HMB-
45. No Epstein-Barr virus-infected cells were identified by
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in situ hybridization for EBER. The feature was suggestive
of fibroleiomyomatous hamartoma rather than primary
leiomyoma. No recurrence has occurred in the 12 months
after surgery, and the patient’s condition has remained
good.
Discussion
Apart from typical hamartomas, Spencer [4] identified
three forms of hamartomatous musculofibrotic changes in
the lung:
1. Single or numerous focal proliferations of the
smooth muscle tissue
2. Pulmonary lymphangioleiomyomatosis
3. Tuberous sclerosis with pulmonary changes
According to Spencer, very rare focal changes occur in
the walls of the pulmonary alveoli, in the pleural region,
and in the walls of the small bronchi. In our case, the
bronchial epithelium extended into the alveolar septa in
the pulmonary parenchyma without a cartilaginous or
adipose element. Spencer suggested that they mainly
developed subpleurally and extended towards the hilum.
In our case, they reached the subpleural space. Patients
with the lesions are generally asymptomatic. Multiple
lesions occur more frequently than solitary lesions, and
the tumors are more prevalent in women. There are
many reports on uterine leiomyomas metastasizing to
the lungs [5].
The histological characteristics of what is currently
referred to as fibroleiomyomatous hamartoma or benign
metastasizing leiomyoma are as follows: (i) a well-
circumscribed nodule composed of smooth muscle cells
with numerous epithelial inclusions and (ii) no cellular
atypia or mitotic figures [6, 7]. In our case, the prolifera-
tion of smooth muscle cells, which were positive for
smooth muscle markers such as alpha-SMA, and the
extension of bronchial epithelium into the alveolar septa
were observed. Neither cellular atypia nor mitotic figures
were present. There are several theories on the pathogen-
esis of this tumor, including (i) that it occurs as a metastasis
from a benign leiomyoma or low-grade leiomyosarcoma
(most often from the uterus); (ii) that it occurs due to the
implantation and proliferation of benign smooth muscle
tissue, which is embolized by intravenous leiomyomatosis
or by mechanical means; and (iii) that they represent true
fibroleiomyomatous hamartoma, originating from the lung.
These tumors are not histologically distinguishable. Ito et
al. reported that the terms fibroleiomyomatous hamartoma
or benign metastasizing leiomyoma could include some
cases of low-grade leiomyosarcomas, true benign
metastasizing leiomyoma, and true fibroleiomyoma [5].
Since controversy exists about the pathogenesis of this
tumor, it was thought that the current diagnostic terms of
fibroleiomyomatous hamartoma or benign metastasizing
leiomyoma should be reconsidered to avoid misleading
diagnoses. In the present cases, the lesion was solitary and
occurred in a male who had no history of smooth muscle
neoplasm. Thus, true fibroleiomyomatous hamartoma was
considered to be the most suitable the diagnostic term to
describe the patient’s condition.
Four partial resections and one lobectomy are reported
to have been performed in the five reported cases of
pulmonary fibroleiomyomatous hamartoma. There are no
reports of the postoperative recurrence of pulmonary fibro-
leiomyomatous hamartoma [2, 3]. We thought preoperative
examinations were atypical as a malignant tumor but could
not deny malignancy. Therefore, we proposed to initially
Fig. 1 Chest computed tomography (CT) revealed a well-demarcated
solid nodule in the right upper lobe adjacent to the pleura, which
measured 1.0 cm in diameter
Fig. 2 The nodule was firm, solid, yellow-white in color on sectioning,
and was not associated with the bronchus or macroscopically
visible bronchioles
Ichiki et al. Surgical Case Reports  (2016) 2:53 Page 2 of 3
perform a partial resection for this peripheral lung tumor.
It was thought that lobectomy should be performed, only
when frozen section had a possibility of malignancy. Surgi-
cal intervention is important, not only for achieving a cure
but also as a diagnostic measure to rule out malignancy.
Complete resection alone seems to be a suitable surgical
treatment.
Conclusions
We herein presented a rare resected case of a solitary
pulmonary fibroleiomyomatous hamartoma and discussed
its differential diagnosis and histogenesis.
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Fig. 3 a The histopathological findings revealed the proliferation of spindle cells with eosinophilic cytoplasm arranged in an interlacing bundle and
bronchial epithelium extending into the alveolar septa in the pulmonary parenchyma without a cartilaginous or adipose element. Mitotic figures were
not observed. b An immunohistochemical analysis revealed that the spindle cells were positive for smooth muscle cell markers such as alpha-smooth
muscle actin (SMA)
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